Mutations in the gene encoding the methyl-CG binding protein MeCP2 cause 35 neurological disorders including Rett syndrome. The di-nucleotide methyl-CG 36 (mCG) is the canonical MeCP2 DNA recognition sequence, but additional 37 targets including non-methylated sequences have been reported. Here we 38 use brain-specific depletion of DNA methyltransferase to show that DNA 39 methylation is the primary determinant of MeCP2 binding in mouse brain. In 40 vitro and in vivo analyses reveal that MeCP2 binding to non-CG methylated 41 sites in brain is largely confined to the tri-nucleotide sequence mCAC. 42
comprise predominantly promoter regions, showed a 56% reduction. 151 Importantly, MeCP2 was expressed at near normal protein levels in Dnmt1 152 KO brains in comparison with age-matched WT brains ( Fig. 1e-f and 153 Supplementary Fig. 1e ). 154
155
To investigate how local loss of DNA methylation quantitatively affects MeCP2 156 binding by chromatin IP (ChIP), we used primers specific for repetitive IAP 157 elements and mouse major satellite sequences (Fig. 1g-h and Supplementary 158 Fig. 1f ) plus four inter-and intra-genic single-copy regions from mouse 159 chromosome 3 ( Supplementary Fig. 1g-k) . Reduced DNA methylation in the 160 conditional mutant brain was confirmed at IAP elements and mouse satellite 161 by bisulfite analysis (Fig. 1i -j) and MeCP2 binding was correspondingly lower 162 ( Fig. 1g-h ). Extending the analysis to unique regions of the genome, we chose 163 four random sites in a relatively gene dense domain ( Supplementary Fig. 1g ). 164
In all replicates MeCP2 binding to each site was consistently reduced in each 165
Dnmt1-deficient brain compared with a matched WT littermate 166 ( Supplementary Fig. 1h-k) . Furthermore, bisulfite analysis confirmed the 167 reduction of DNA methylation at the nucleotide level in each case 168 ( Supplementary Fig. 1l-o) . The data for 6 randomly chosen regions of the 169 mouse genome provide strong support for the conclusion that DNA 170 methylation is a major determinant of MeCP2 binding in the mouse brain. 171 172
MeCP2 recognizes modified di-and tri-nucleotide sequences 173
The predominant methylated sequence is the di-nucleotide CG, but in adult 174 brain mCA 3 and hmCG 17,35 are implicated as binding partners of MeCP2. A 175 recent study concluded that in addition to mCG, MeCP2 binds both mCA and 176 hmCA 25 and confirmed earlier reports that hmCG is a low-affinity binding site 177 for MeCP2 25,36-38 . In addition MeCP2 has been reported to bind in vitro to 178 DNA in which every cytosine was substituted with hmC 17 . Given that neurons 179 only accumulate significant levels of both hmCG and mCH (where H is any 180 base except G) from two weeks postnatally 3 , the Dnmt1 KO model is unsuited 181 to investigate additional sequence specificities of methylation dependent 182
MeCP2 binding. To comprehensively analyze the DNA sequence 183 determinants of MeCP2 binding in vitro we performed EMSA using the 1-205 N-terminal domain of MeCP2 that contains the MBD. Surprisingly, the data 185 revealed a further constraint on MeCP2 binding, as the third base following 186 mCA strongly affected MeCP2 binding affinity in vitro ( Fig. 2a ). Probes 187 containing the mCAC tri-nucleotide sequence bound with high affinity to 188
MeCP2, whereas probes containing mCAA, mCAG and mCAT bound much 189 less strongly. This result was confirmed in EMSA experiments using all 190 possible mCXX tri-nucleotide sequences as unlabeled competitors against a 191 labeled mCGG-containing probe (Fig. 2b ). Quantification showed that mCAC 192 and, to a lesser extent mCAT, are both effective competitors, but mCAG and 193 mCAA compete no better than non-methylated control DNA (Fig. 2c ). All 194 mCGX oligonucleotide duplexes competed strongly indicating that the base 195 following mCG on the 3' side does not have a large effect on binding, 196 although we note that mCGA was reproducibly a weaker competitor than 197 mCGC, mCGG or mCGT. Neither mCCX nor mCTX tri-nucleotides have a 198 significant affinity for MeCP2 in vitro. 199
200
As hmCA is reported to bind MeCP2 in vitro 25 , we asked whether the third 201 base is also important for hmC binding. Using hmCXX tri-nucleotides as 202 probes in EMSAs, we found that hmCAC bound with a much higher affinity 203 than hmCAA, hmCAG and hmCAT DNA (Fig. 2d ). It is notable that the great 204 majority of hmC in the brain and elsewhere is in the hmCG di-nucleotide, with 205 hmCAC being extremely rare 3 . The DNA binding specificity of MeCP2 MBD 206 deduced from these in vitro experiments is summarized in a matrix of di-and 207 tri-nucleotide sequences that bind to MeCP2 (red lettering, Fig. 2e ). 208 209
MeCP2 binding specificity in vivo 210
To determine whether the binding specificities established in vitro apply to full-211 length protein in living cells, we developed a novel assay using transfection 212 followed by ChIP 39 . Synthetic DNA duplexes containing specific cytosine 213 modifications were transfected into HEK293 cells expressing human MeCP2 214 tagged with GFP ( Fig. 3a and Supplementary Fig. 2a-b ). Levels of 215 endogenous MeCP2 in these cells are negligible and therefore do not 216 interfere with the assay ( Supplementary Fig. 2c ). We tested oligonucleotide presence of the cytosine hydroxyl group would not be accommodated due to 253 the close proximity of this polar group with the guanidinium group of R111 254 ( Supplementary Fig. 3d ). Binding of hmCAC is allowed, however, due to tilting 255 of the R133 side-chain and the formation of hydrogen bonds with guanine on 256 the opposite DNA strand ( Supplementary Fig. 3e ). The presence of a purine 257 in the third position of hmCAG and hmCAA introduces a clash that is not 258 observed with hmCAC or hmCAT (data not shown). Thus the observed tri-259 nucleotide binding specificity of MeCP2 can theoretically be explained with 260 minimal perturbation of the established X-ray structure of the MBD-DNA 261 complex. The minimal change to the structure of the MBD required to 262 accommodate either mCG or mCAC raises the possibility that the biological 263 consequences of binding either motif will be the same. 264
265
A prediction of the modeling is that MeCP2 should bind in only one orientation 266 to mCAC or mCAT, whereas binding to the symmetrical mCG dyad may occur 267 in either orientation. The model requires that R111 and D121 interact with the 268 methyl group of thymine rather than that of 5mC ( Fig. 4b ). As thymine is 269 effectively 5-methyluracil ( Fig. 4c ), we replaced it with uracil in the labeled 270 probe and performed EMSA analysis ( Fig. 4d ). Loss of the thymine methyl 271 group abolished binding to MeCP2, in agreement with the hypothesis that 272
MeCP2 binding to mCAC is confined to one orientation. The data suggest that 273 a symmetrical pair of 5-methyl pyrimidines, one of which is mC, offset by one 274 base pair is an essential pre-requisite for MBD binding to DNA. 275
276

DNA sequence specificity of MeCP2 binding in adult mouse brain 277
To test whether the DNA binding specificities established in vitro and in 278 transfected cells also apply in native tissues, we analyzed MeCP2 ChIP-seq 279 and whole genome bisulfite (WGBS) datasets derived from adult mouse brain 280 (references 3,25,26 and WGBS from sorted neurons and WGBS from 281 hypothalamus this study). CG is under-represented in the mouse genome 282 (~4% of CX), but highly methylated (~80%), whereas CA is the most abundant 283 CX di-nucleotide (36% of CX), but even in brain only a small fraction of CA is 284 methylated (<2%) ( Fig. 5a-c ). Bisulfite analysis of sorted neurons by NeuN 285 staining 16 confirmed previous reports that CAC is the most methylated tri-286 nucleotide 2,8 , being ~12% methylated (Fig. 5c ). The finding that the MeCP2 287 tri-nucleotide binding specificity matches the most abundantly methylated 288 non-CG sequence in brain encourages the view that this interaction is 289 biologically relevant. 290 291 Previous ChIP-seq analyses have concluded that the read coverage of 292
MeCP2 chipped samples tracks the density of CG methylation 15, 16, 25, 26 . Re-293 analysis of several MeCP2-ChIP data sets for which the antibody used has 294 been rigorously verified, indicates, however, that the profile of Input -295 specifically, DNA derived from the fragmented chromatin sample used for 296
ChIP -is closely similar to that of MeCP2 ( Fig. 5d ). Using the published high 297 quality ChIP-seq dataset for hypothalamus 26 , we fitted a linear model to 298 predict MeCP2 read coverage from Input reads alone and found a coefficient 299 of determination of 0.84, indicating that MeCP2 is almost uniformly distributed 300 across the genome at this resolution ( Fig. 5e ). These results are in line with a 301 previous report that the number of MeCP2 molecules in mature neurons is 302 sufficient to almost ''saturate'' mCG sites in the genome 16 . Given the similarity 303 between ChIP and Input, we focussed on regions that show deviations from 304 the Input profile regarding enrichment (purple) or depletion (green) of MeCP2 305 ( Fig. 5f ). First, we investigated genomic regions that are depleted of potential 306 binding sites, e.g. unmethylated CpG islands (CGIs). As the ChIP dataset was 307 derived from mouse hypothalamus, we performed WGBS on three biological 308 replicates of this brain region (see Online Methods). Using ChIP and DNA 309 methylation datasets from the same brain region, we observed a pronounced 310 drop of the log2(MeCP2/Input) signal across CGIs for two different data sets, 311 confirming previous analyses 16,25,26 ( Supplementary Fig. 4a ). We next 312 examined regions where the MeCP2 signal was higher than expected by 313 applying the MACS 41 tool to detect summits of MeCP2 binding peaks relative 314 to Input 25 . As expected, the di-nucleotide mCG showed a sharp peak at 315
MeCP2 ChIP summits in the hypothalamus dataset ( Supplementary Fig. 4b -e 316 and 25 ). In addition, the tri-nucleotide mCAC, but not other mCAX tri-317 nucleotides, coincided strikingly with MeCP2 peak summits, confirming that 318 mCAC provides a focus for MeCP2 binding ( Supplementary Fig. 4i ). Regarding 321 targeting of mCAT, which bound relatively weakly in EMSA, but strongly in the 322 transfection assay, the ChIP-seq data suggest that this is a relatively low 323 affinity site in native brain ( Fig. 5g-h and Supplementary Fig. 4f -h). 324
325
To establish MeCP2 binding preferences across the whole genome we 326 adopted a sliding window approach. In the Input sample, both, mCG density 327 and density of unmethylated CGs strongly correlated with coverage revealing 328 a methylation independent CG sequencing bias (data not shown). In contrast, 329 the MeCP2 ChIP coverage was DNA methylation sensitive, with mCG being 330 positively correlated, while unmethylated CG density was anti-correlated (data 331 not shown). Importantly, DNA methylation-sensitivity was also observed in the 332
Input-corrected signal (log2(MeCP2/Input)), strongly supporting the view that 333 mCG is targeted by MeCP2 binding (Fig. 5i , Supplementary Fig. 4j , l). This 334 mCG binding preference was independent of the third DNA base 335 ( Supplementary Fig. 4n ). In agreement with the in vitro and in vivo results 336 reported above, the density of mCAC correlated strongly with increasing 337
MeCP2 enrichment, whereas a much weaker trend was observed for other 338 methylated tri-nucleotide sequences ( Fig. 5j , Supplementary Fig. 4k , m). We 339 found no evidence for MeCP2 binding to hmCG or unmethylated C's in any 340 sequence context ( Supplementary Fig. 4j , l, o-r). To complement the sliding 341 window approach, we focused on MeCP2 binding within gene bodies and 342 found once again that the Input-corrected signal is strongly correlated with the 343 density of mCG and mCAC (Fig. 5k ). The ChIP data therefore sustain the 344 view that MeCP2 binding is determined by the combined density of mCG and 345 mCAC sites. These regions share common sequence features, in particular high mCG and 356 mCAC densities ( Fig. 5m , Supplementary Fig. 4t -u). We also identified a large 357 number of short regions containing highest GC content (<1 kb) but are 358 strongly depleted in MeCP2 binding. As expected, these regions significantly 359 overlap with CGIs ( Supplementary Fig. 4s ). Lastly, we found a third group of 360 relatively long regions (10 kb -1 Mb) which are moderately depleted in 361
MeCP2 binding (MeCP2 enrichment score: <0). These regions are 362 moderately enriched for mCG but lack mCAC ( Fig. 5m , Supplementary Fig.  363 4s-u). 364
365
As part of this binding site analysis we re-visited an earlier report that MeCP2 366 binds preferentially to mCG flanked by an AT-rich run of 4-6 base pairs in 367 vitro 43 . To look for this preference in brain, we asked whether isolated mCG 368 and mCAC flanked by a run of 4 or more A or T base pairs within 13 base 369 pairs showed greater MeCP2 ChIP-seq signal than sequences lacking an AT 370 run. In summary, we find no evidence for an effect of AT-flanks on MeCP2 371 binding site occupancy, suggesting that the in vitro preference might not be 372 biologically relevant in vivo ( Supplementary Fig. 4v-w) . 373 374
The relationship between MeCP2 occupancy and gene expression 375
The association of MeCP2 with both methylated sites in the genome and the 376 co-repressor complex NCoR 13 suggests that the protein can function to inhibit 377 transcription. If so, a relationship would be expected between MeCP2 378 occupancy and the transcriptional mis-regulation seen when MeCP2 is either 379 depleted by deletion of the gene (KO) 31 or over-expressed (OE) 44,45 . Before 380 making use of published datasets for mouse hypothalamus 26 , we first asked, 381 using HPLC, whether the absence or over-expression of MeCP2 alters total 382 RNA levels. Previous studies using MeCP2-deficient neurons differentiated in 383 vitro from mouse ES cells or human iPS cells reported reduced total RNA and Over-expression of MeCP2, however, did not significantly affect total RNA. As 389 the latter is ~98% ribosomal RNA, we asked whether mRNA levels were also 390 reduced in KO hypothalamus. Quantitative RT-PCR (qPCR) using spiked-in 391
Drosophila cells to control for experimental error and normalized to brain cell 392 number in each sample ( Supplementary Fig. 5b ) confirmed that genes 393 previously reported to be up-or down-regulated in MeCP2-deficient 394 hypothalamus 26 were similarly mis-regulated in our samples (Supplementary 395 Fig. 5c-f ). We then measured the abundance of three housekeeping genes 396 and found that all were down-regulated by approximately 15% 397 ( Supplementary Fig. 5g -i). These results suggest that total RNA and mRNA 398 levels are coordinately reduced and we have therefore applied this 399 normalization to all hypothalamus RNAseq datasets. The mechanisms 400 responsible for reduced total RNA, and whether this effect is a primary or 401 secondary consequence of MeCP2 deficiency, are unknown. 402
403
We next examined gene expression by separating genes whose expression 404 was increased, unchanged or decreased in response to changing levels of 405 the transcription start and end sites. We also asked whether the increased 416 MeCP2 occupancy measured by ChIP-seq in hypothalamus correlated with 417 an elevated level of the two target sequences mCAC and mCG. The 418 distribution of mCAC strikingly matched the pattern of MeCP2 binding ( Fig. 6b , 419 e), but mCG, which occurs at much higher density, correlated less obviously The strong reciprocal relationship between MeCP2 occupancy and the 422 direction of gene mis-regulation in KO and OE hypothalamus respectively, is 423 compatible with the notion that MeCP2 binding is inhibitory to transcription. 424
Excess MeCP2 preferentially inhibits genes with most binding sites whereas 425 its depletion preferentially de-represses highly occupied genes. Elevated or 426 depleted MeCP2 binding extended up-and down-stream of the TSS, 427
suggesting that these genes are embedded within the extended MeCP2 428 domains identified by our MSR analysis ( Fig. 5l-m significantly increased their expression per cell compared with WT ( Fig. 6i , 443 purple). These genes, which shared high MeCP2 occupancy ( Fig. 6i , lower 444 panel), showed the inverse behavior in OE hypothalamus where they were 445 down-regulated ( Fig. 6j ). This inverse relationship is readily apparent in a plot 446 of gene expression changes in KO/OE hypothalamus ( Supplementary Fig. 6g ). 447
De-regulated genes shared similar levels of mCG density, but only the up-448 regulated genes displayed increased mCAC ( Supplementary Fig. 6h -i). We 449 noted that the genes up-regulated in KO were significantly longer than 450 average, in agreement with a report that long genes are preferentially up-451 regulated in MeCP2 KO mice 25 ( Supplementary Fig. 6c ) and most were 452 whole mouse brain 16 , hypothalamus 26 , cortex and cerebellum 25 coupled with 484 DNA methylation-dependent occupancy of the genome. A potential 485 explanation for the discrepant results in olfactory bulb is that the rules 486 governing MeCP2 binding in this region of the brain differ from those 487 operating in the remainder of the nervous system. Alternatively, there may be 488 a technical issue regarding antibody specificity that has led to inconsistent 489 findings. It is notable that the earlier reports showing DNA methylation 490 dependence were achieved using a diversity of validated antibodies. 491
DNA methylation-dependent recognition sequences of MeCP2 493
We comprehensively analyzed the modified DNA sequences that determine 494
MeCP2 binding. To insure the reliability of our conclusions we used three 495 experimental approaches: in vitro EMSA; in vivo ChIP in transfected cultured 496 cells; and in vivo ChIP-seq of mouse brain. Three methylated DNA motifs 497 consistently recruited MeCP2: mCG, mCAC and hmCAC. Interestingly, mCAC 498 is the predominant methylated non-CG sequence in brain, comprising 15 -499 30% of all methylated cytosine in sorted mouse neurons, probably due to the 500 action of the de novo DNA methyltransferase Dnmt3a 2,4 . The 501 hydroxymethylated sequence hmCAC, on the other hand, is reportedly 502 extremely rare perhaps due to the preference of Tet enzymes for mCG as a 503 substrate 3 . Given the inability of MeCP2 to bind hmCG and the apparent 504 extreme rarity of hmCAC, it seems unlikely that hmC is a major contributor to 505 the biological role of MeCP2. 506
507
Our modeling provides a structural explanation for the sequence specificity of 508 the interaction between MeCP2 and DNA. We previously observed that the 509 replacement of a mC at a methylated CG di-nucleotide with T, forming a T:G 510 mispair, had a negligible effect upon the binding affinity of MeCP2 36 , 511
indicating that hydrogen bonding with the mC/T is not essential and that the 512 interaction is flexible enough to accommodate the T:G wobble geometry. Here 513 we observed that in duplex DNA pyrimidine-methyl groups can be provided by 514 either the mC or T, as demonstrated by the finding that the replacement of T 515 with U, which lacks the T methyl group, results in loss of MeCP2 binding. 516
Remarkably the observed specificity for mC in either mCG or mCAC 517 sequence contexts can be rationalized with minimal changes to the 518 conformation of the MBD that was established by X-ray crystallography 40 . 519
Only the configuration of the side-chain of amino acid arginine 133 needs to 520 be adjusted to account for both permitted and non-permitted interactions. The 521 model has potentially important biological consequences, as it suggests that 522 binding to mCAC or mCG is structurally very similar, making it likely that 523
MeCP2 binding to any of these sequences will lead to the same outcome 524 down-stream. In agreement with this scenario, experiments comparing 525 reporters methylated at mCA or mCG suggest that both modified sequences lead to transcriptional repression 2 . Missense mutations that cause Rett 527 syndrome predominantly affect the MBD or the NID, suggesting that the 528 primary role of MeCP2 is to bridge DNA sequences with the NCoR/SMRT co-529 repressor complexes 13 . We propose that mCG and mCAC, function identically 530 to facilitate this bridging process. 531 532
MeCP2 binding profiles and gene expression 533
The high frequency of mCG and mCAC binding sites for MeCP2 throughout 534 the neuronal genome (one per ~100 bp) poses problems for conventional 535
ChIP-seq analysis. In most studies binding sites of, for example, transcription RNA, matching reports in cultured mouse and human neurons 24,46 . The 547 mechanism responsible is unknown, but one possibility is that MeCP2 is a 548 direct global activator of transcription 23,24 . Arguing against this possibility, we 549 found that most KO down-regulated genes lie in domains of low MeCP2 550 occupancy. Also, it might be expected that two-fold over-expression of an 551 activator would lead to increased levels of RNA compared to WT, but this is 552 not observed ( Supplementary Fig. 5a ). An alternative explanation is that 553 reduced RNA reflects reduced cell size, perhaps as a secondary 554 consequence of sub-optimal neuronal gene expression. In this case the 555 change in total RNA and the relative mis-regulation of genes within the RNA 556 population may be separate phenomena. Given the close relationship 557 between gene mis-regulation, MeCP2 binding site density and MeCP2 558 occupancy, we favor the view that the effects of MeCP2 concentration on the 559 balance of neuronal gene expression are primary, whereas the downward shift in total RNA is a secondary effect. To test this rigorously it will be 561 important to track down the origins of the total RNA deficiency. 562 563 By re-analyzing ChIP-seq and RNA-seq datasets from hypothalamus of WT 564 mice, Mecp2-null mice and mice over-expressing MeCP2 we were unable to 565 confirm reports that MeCP2 is more highly bound to the transcription units of 566 mis-expressed genes regardless of up-or down-regulation 26 . Instead we 567 found that MeCP2 is bound at higher levels within and surrounding genes that Alternatively, the regulatory influence of MeCP2 may operate over large 607 domains encompassing many genes. Future research will attempt to 608 distinguish these possibilities. 609 610
Subtle effects on transcription of many genes 611
While there is no direct evidence that aberrant gene expression is the 612 proximal cause of Rett syndrome or MeCP2 over-expression syndrome, it is 613 noteworthy that thousands of genes, including many implicated in human 614 neuronal disorders, are sensitive to altered levels of MeCP2. Mild mis-615 regulation on this scale may destabilize neuronal function 25 . It is worth 616 recalling that Rett neurons, though sub-optimal, are viable for many decades. 617
In this sense the biological defect can be seen as mild, despite the profound 618 effects on higher functions of the brain. The challenge now is to determine 619 how brain function might be affected by a multitude of small discrepancies in 620 gene expression. Overall, the results presented here sustain a coherent view 621 of MeCP2 function: namely that MeCP2 binding at mCG and mCAC sites 622 determines the magnitude of a repressive effect on transcription that is 623 exacerbated by MeCP2 excess and relieved by MeCP2-deficiency. With the 624 benefit of a comprehensive list of MeCP2 target sequences at the molecular 625 level, the predictions of this model can be experimentally tested, clarifying 626 further the role of MeCP2 in regulating transcription in the brain.
Online Methods 628 629
Animal care and transgenic mouse lines 630
All mouse studies were approved by the Austrian Animal Care Committee and 631
were licensed under the UK Animals (Scientific Procedures) Act 1986 and 632 mouse specific mRNA and genomic DNA primers. For analysis, mouse mRNA 652 was normalized to Drosophila RNA and analogous mouse DNA was 653 normalized to Drosophila DNA. In the final step, corrected mRNA levels were 654 normalized to corrected DNA values. Primer sequences can be found in 655 Supplementary Table 3 . 656
Nuclear protein extracts and Western blotting 662
Whole brain protein extracts were prepared as previously described with 663 modifications 13 . After homogenization in NE10 buffer and addition of 250 units 664 Supplementary Table 1 ). The primary cytosine of this tri-nucleotide was 692 either non-methylated, methylated, or hydroxymethylated. All oligonucleotides 693 were annealed to their complement, 32 P-labelled and electrophoretic mobility previously 43 . In competition assays to assess tri-nucleotide-binding 696 preferences of MeCP2 [1-205] a parent 58 bp Bdnf-probe, containing the 697 centrally methylated sequence mCGG, was 32 P-labelled and co-incubated 698 with a 2000-fold excess of cold-competitor DNA bearing one of the sequences 699 described in Fig. 2b-c . Bound complexes were resolved as described above Cells were then crosslinked with formaldehyde to 1% final concentration for 5 770 minutes at room temperature and quenched by the addition of glycine to a 771 final concentration of 0.125M for 5 minutes followed by another two washes in 772 PBS. Cell pellets were flash frozen in liquid nitrogen and stored at -80°C or 773 directly used for chromatin isolation and consecutive ChIP with 4μg MeCP2 774 M6818 antibody (Sigma). Primer sequences can be found in Supplementary 775 Table 2 . 776 777
Mouse brain chromatin preparation 778
Frozen or fresh mouse brains were homogenized in PBS supplemented with 779
Protease Inhibitor Cocktails (Roche) and crosslinked with formaldehyde to 1% 780 final concentration for 10 minutes at room temperature. After quenching the 781 crosslink with 0.125M glycine, brains were washed in ice cold PBS twice and 782 soluble chromatin preparation was performed. 783 784
Chromatin preparation and ChIP 785
Soluble chromatin preparation and ChIP assays were carried out as described 786 previously 54 with some modification. In short, chromatin was sonicated using Supplementary Table 2 .
Structural modeling 798
Modeling was based on the X-ray structure of MeCP2 (PDB code 3C2I) using 799 the program COOT 55 . Atomic coordinates for DNA bases were generated 800 using the 'mutate' option. To optimize hydrogen-bonded and van der Waals 801 contacts between protein and different base pair sequences, the conformation 802 of the side chain of R133 was adjusted manually (all other atoms in the 803 structure were left unchanged). The potential role of water molecules in the 804 recognition of different base-pair sequences by MeCP2 was examined by 805 placing a water molecule in the highly conserved and most probable sites of 806 hydration in the major groove of B-DNA as described 56 . All figures were 807 prepared using the graphics program PyMol (DeLano Scientific, San Carlos, 808 CA). 809 810
Locus-specific bisulfite sequencing 811
Bisulfite treatment of genomic DNA of P11 WT and Dnmt1 KO whole brain 812 triplicates and DNA sequencing was carried out as previously described 57 with 813 some modifications. Genomic DNA was isolated with the DNeasy Blood & 814
Tissue kit (Qiagen) and bisulfite treated with the EpiTect bisulfite kit (Qiagen). 815
Bisulfite Primers were designed with MethPrimer software 58 . Sequences were 816 analyzed with the BISMA online tool 59 . 817 818
Reduced representation bisulfite sequencing 819
Genomic DNA from whole brain of 5 day old Dnmt1 WT and KO littermate 820 replicates was isolated using the DNeasy Blood & Tissue Kit (Qiagen). For 821 RRBS 34 , the "Reduced Representation Bisulfite Sequencing for Methylation 822
Analysis" protocol (www.support.illumina.com) was followed and TruSeq® v2 823 
Genome build and annotations 849
All data were aligned to the mouse NCBI 37 (mm9) assembly. Gene 850 annotations were obtained from version 67 of the Ensembl database. 851
ChIP-seq 852
MeCP2 Chip and Input datasets were downloaded from the Gene Expression 853
Omnibus (GEO) under the accession numbers GSE66868 26 and GSE60062 25 . 854
Raw sequencing reads were first trimmed and filtered using Trimmomatic 855 v0.32 61 then aligned with bwa using the samse algorithm. Alignments were 856 then filtered to remove reads classed as duplicates, non-unique or those that 857 fell in the blacklisted regions outlined by the Encode project 62 . Alignments 858 were converted to bigWig files using the deepTools package for genome wide 859 visualization and analysis. Read counts were normalized to RPKM to account 860 for differences in library size. The bigwigCompare tool was used to calculate a
Whole genome bisulfite sequencing of mouse hypothalamus 865
Quality trimming, filtering and adapter removal were performed by 866 trimmomatic v0.32 prior to alignment. The software package Bismark v0.15 867 was used to map reads to the mm9 genome, remove duplicate alignments 868 and extract methylation calls 63 . 869
BS-seq and TAB-seq 870
Processed bisulfite and TAB-seq datasets containing aligned methylation calls 871 were obtained from the GEO records GSM1173786_allC.MethylC-872
Seq_mm_fc_male_7wk_neun_pos
and GSM1173795_allC.TAB-873 where is the number of C's within the region, occurring in context . In 878 addition, context-specific methylation density was defined as
is the length of the region. 880
RNA-seq 881
Raw reads from mouse hypothalamus were downloaded from the Gene 882 Expression Omnibus (GEO) under the accession no. GSE66870 26 . 883 Trimmomatic v0.32 was used to remove adaptor contamination and to trim 884 low quality reads. Reads were mapped to the genome using STAR v 2.4.2a 64 . 885
Alignments were then filtered to remove non-unique and blacklisted reads. 886
HTseq-count v0.6.0 was used to quantify read counts over gene exons in the 887 union mode. 888
Correlation between MeCP2 ChIP-Seq and Input read counts (Fig. 5e-f 
897
Correlation between log2(MeCP2/Input) and DNA methylation in genomic 898 windows (Fig. 5i-j and Supplementary Figs. 4j-r 
) 899
We calculated read coverage values and context-dependent methylation 900 densities for 1 kb windows across the genome. Regions were ordered by their 901 log2(MeCP2 Chip/Input) signal and mean methylation densities were 902 calculated for groups of 1000 regions. Datasets used are 26 and 903 hypothalamus WGBS (this study). 904
MeCP2 summit analysis (Fig. 5g-h 
and Supplementary Figs. 4b-i) 905
Summits of MeCP2 ChIP enrichment over Input were defined using MACS 906 and the method described in 25 for both MeCP2 datasets ( 25,26 ). We used the 907
Bioconductor package seqplots v1.4.0 to plot methylation density across the 908 summits for various cytosine contexts. Mean methylation densities were 909 calculated for 20 bp windows across the summits extended by 4 kb on either 910 side. The ChIP-seq dataset from cortex was combined with bisulfite analysis 911 from 3 ( Fig. 5g and Supplementary Figs. 4i, l-m) and the hypothalamus ChIP-912 seq dataset 26 was correlated with bisulfite data from hypothalamus WGBS 913 (this study) ( Fig. 5h and Supplementary Figs. 4b-h and n-r) or bisulfite data 914 from 3 ( Supplementary Figs. 4j-k) . 915
Rolling mean plots for genic regions (Fig. 5k ) 916
Genes were sorted according to their MeCP2/Input enrichment and rolling 917 means of methylation density were applied over subsets of 400 genes with a 918 step of 80 genes. Datasets used are 26 and hypothalamus WGBS (this study). 919 MSR (Fig. 5 l-m and Supplementary Figs. 4s-u ) 920
We used the MSR tool to find domains of MeCP2 enrichment and depletion 921 relative to the Input sample 42 . As background we used a mappability map for 922 the m9 genome (parameters: L=45, P-value threshold: 1e-6). For each 923 significantly enriched or depleted segment we determined the methylation 924 densities and averaged over segments with same scale and enrichment score.
We used DeSeq2 v1.8.1 65 to determine mis-regulated genes in KO and OE. 928 To account for the observed 15% reduction of total mRNA in the KO samples, 929
we first used the DESeq function estimateSizeFactors to normalize the data 930 sets and subsequently multiplied the obtained size factors for the KO samples 931 by 1.15. An adjusted p-value threshold of <0.05 was used to determine up-or 932 down-regulated genes. For an exemplary group of genes for which little 933 change is observed between conditions we used p_adj >0.5 with a 934 log2FoldChange <0.01. We further filtered out protein-coding genes with 935 constitutively low expression (TPM <5 in all samples) and genes with the 936 lowest Input coverage. We retained 12,510 protein-coding genes, of which 937 403 showed higher, and 8363 lower expression in KO vs WT, respectively. In 938 addition, we found 1372 to have higher and 2719 to have lower expression in 939 OE relative to WT. Dataset used is 26 . 940
Aggregated signal plots across gene features (Fig. 6a-f and Supplementary 941
Fig. 4a) 942
We used seqplots to generate aggregate plots at transcription start sites of 943 protein coding genes and annotated CGIs. Mean values for log2(MeCP2 944 ChIP/Input) and methylation densities were calculated over 1 kb windows for 945 each set of genes and 100 bp windows for CGIs ( Supplementary Fig. 4a 
